Tag: androgen-receptor

Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ

Enobosarm in AR-positive, ER-positive, and HER2-Negative Advanced Breast Cancer

byDaniel Goldshteinand1 others

February 19, 2024

1. The clinical benefit rate was 32% in the 9 mg group and 29% in the 18 mg group. 2. ...

Patient-reported outcomes differ significantly based on treatment in prostate cancer: The ProtecT trial

Darolutamide improves overall survival in patients with hormone-sensitive prostate cancer

byBoaz Wongand1 others

March 28, 2022

1. Patients with hormone-sensitive prostate cancer receiving darolutamide, an androgen-receptor inhibitor, in addition to standard therapy demonstrated longer overall survival ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result